02/11/2026
MCA Holds Close-Out Workshop to Present its AU-3S Project Final Report
The Medicines Control Agency (MCA) held a close-out workshop on 30 October 2026 to present the final report of the African Union Smart Safety Surveillance (AU-3S) project which supported it Pharmacovigilance function, including its findings, lessons learned and sustainability plan. The event marked the official end of the project and took place at the National Association of Cooperative Credit Unions of The Gambia (NACCUG) Hall in Bakau.
In her opening remarks, the Director of Clinical Trials and Pharmacovigilance, Ms. Fatou Njie, explained that the project was set up to strengthen The Gambia’s pharmacovigilance (PV) system, following a visit to MCA by the AU-3S Team from the African Union Development Agency (AUDA-NEPAD), in June 2025, to assess the country’s safety surveillance system.
The team also discussed how the program could support the PV system and close the gaps identified during the assessment of the PV system.
Participants from the Health sector, including the Ministry of Health, National Health Programmes, Regional Health Directorates, hospitals and the Medicine Safety Expert Committee, and other stakeholders, to discuss the findings and made recommendations on how to sustain the result gained and to also boost the Pharmacovigilance system.
Director Njie commended all stakeholders for their contributions to the success of the project and their continued participation in strengthening the country’s PV system.
For MCA, although the project has ended, the work continues to ensure that The Gambia gets quality, safe and efficacious medicines.